$100 Million awarded Since 1994 6,000 Satisfied Clients

Posted On October 8, 2024 Securities

Outset Medical Class Action Lawsuit (OM)

NOTICE: If you suffered Outset Medical investment losses, contact the securities attorneys at Console & Associates to discuss your legal options. Submit a confidential Case Evaluation form here.

You may be eligible to join the Outset Medical class action lawsuit if you are an investor who was shaken by a series of disclosures leading to significant stock price declines. Between August 1, 2022, and August 7, 2024, the company made statements now under scrutiny, culminating in a class action lawsuit alleging securities fraud. If you suffered investment losses as a result, complete our online form and our securities lawyers will be able to assist.

Key Allegations Against Outset Medical

The Outset Medical class action lawsuit claims that the company and certain executives made false and misleading statements by failing to disclose critical information. It is alleged that the company marketed Tablo products for uses not approved by the FDA and did not reveal the likelihood of needing additional FDA approvals for certain products. Moreover, the company risked potential pauses in product shipments pending FDA clearances and lacked the necessary sales team and processes to effectively scale up Tablo sales. These actions reportedly misrepresented revenue growth prospects, which were negatively impacted as a result.

Timeline of Critical Events

  • On July 7, 2023, Outset Medical disclosed receiving an FDA warning letter concerning off-label marketing practices.
  • This was followed on August 2, 2023, by an announcement of a pause in shipments of TabloCart pending FDA clearance, raising concerns about future sales.
  • On October 12, 2023, the company revealed that the FDA warning letter had significantly impacted revenue growth.
  • On August 7, 2024, Outset Medical released Q2 2024 financial results that missed estimates and lowered future guidance, citing the need for “sales team and process restructuring.” The stock price fell sharply following this news.

Impact on Investors

These revelations led to a substantial decline in Outset Medical’s stock price, causing significant financial losses for investors. The Outset Medical class action lawsuit alleges that investors purchased shares at artificially inflated prices due to the company’s misleading statements and omissions.

Your Rights as an Investor

If you purchased Outset Medical securities during the period from August 1, 2022, to August 7, 2024, you may be eligible to join the class action lawsuit. Participating in the lawsuit could help you recover your losses, hold the company accountable for its actions, and promote corporate transparency in the market.

Why Act Now?

Time is of the essence in securities litigation. Acting promptly can:

  • Maximize Your Potential Recovery: Early participants may have more influence on the proceedings.
  • Protect Your Legal Rights: Statutes of limitations may limit your ability to seek compensation if you delay.
  • Send a Message: Demonstrate that investors will not tolerate misleading practices.

Take the First Step

Don’t let misinformation jeopardize your financial future. Contact the securities lawyers of Console & Associates, P.C. for a free, no-obligation consultation to discuss your options.

NOTICE: If you suffered Outset Medical investment losses, contact the securities attorneys at Console & Associates to discuss your legal options. Submit a confidential Case Evaluation form here.